OncLive.com· @OncLive · X·· 1 day agoScore70
Body · original
It's time!! The second Presidential Symposium is officially underway. Check back tonight for live coverage of Krascendo 1, SAFFRON, CLARITY-Gastric 01, and HARMONi-GI1 @myESMO #ESMO26 #Oncology
111 views · 0 likes · 0 reposts · 0 replies
Conference abstracts
CLARITY-Gastric 02: A randomised phase 3 study of sonesitatug vedotin (Sone-Ve) and capecitabine with or without rilvegostomig in Claudin18.2 positive (CLDN18.2+) advanced or metastatic gastric, gastroesophageal junction, or oesophageal ade
https://esmocongress.esmo.orgKrascendo 3: A randomised, phase III trial in progress of divarasib vs immunotherapy or observation in patients with resected, stage II-IIIB, KRAS G12C+ non-small cell lung cancer
https://esmocongress.esmo.orgSource: OncLive.com · x.com
